Engineering designer beta cells with a CRISPR-Cas9 conjugation platform D Lim, V Sreekanth, KJ Cox, BK Law, BK Wagner, JM Karp, A Choudhary Nature Communications 11 (1), 4043, 2020 | 48 | 2020 |
A Singular System with Precise Dosing and Spatiotemporal Control of CRISPR‐Cas9 D Manna, B Maji, SA Gangopadhyay, KJ Cox, Q Zhou, BK Law, ... Angewandte Chemie 131 (19), 6351-6355, 2019 | 48 | 2019 |
Chemogenetic system demonstrates that Cas9 longevity impacts genome editing outcomes V Sreekanth, Q Zhou, P Kokkonda, HC Bermudez-Cabrera, D Lim, ... ACS central science 6 (12), 2228-2237, 2020 | 19 | 2020 |
Reconstructing axial progenitor field dynamics in mouse stem cell-derived embryoids A Bolondi, BK Law, H Kretzmer, SI Gassaloglu, R Buschow, ... Developmental Cell, 2024 | 9 | 2024 |
A general approach to identify cell-permeable and synthetic anti-CRISPR small molecules D Lim, Q Zhou, KJ Cox, BK Law, M Lee, P Kokkonda, V Sreekanth, ... Nature Cell Biology 24 (12), 1766-1775, 2022 | 9 | 2022 |
Efficient prime editing in two-cell mouse embryos using PEmbryo RP Kim-Yip, R McNulty, B Joyce, A Mollica, PJ Chen, P Ravisankar, ... Nature Biotechnology, 1-9, 2024 | 7 | 2024 |
A molecular glue approach to control the half-life of CRISPR-based technologies V Sreekanth, M Jan, KT Zhao, D Lim, JR Davis, M McConkey, V Kovalcik, ... bioRxiv, 2023 | 3 | 2023 |
Inferring cell differentiation maps from lineage tracing data P Sashittal, R Zhang, B Law, A Strzalkowski, H Schmidt, A Bolondi, ... bioRxiv, 2024.09. 09.611835, 2024 | 1 | 2024 |
Inhibitors of rna-guided nucleases and uses thereof A Choudhary, D Lim, Z Qingxuan, K Cox, B Law, LEE Miseon, ... US Patent App. 18/361,352, 2024 | | 2024 |
A conjugation platform for CRISPR-Cas9 allows efficient β-cell engineering D Lim, V Sreekanth, KJ Cox, BK Law, BK Wagner, JM Karp, A Choudhary bioRxiv, 732354, 2019 | | 2019 |
A molecular glue approach to control the half-life of CRISPR-based technologies V Sreekanth, M Jan, KT Zhao, D Lim, JR Davis, M McConkey, V Kovalcik, ... bioRxiv, 0 | | |